Metal biology: Aspects of beneficial effects

Ambio

Volumn 36, Issue 1, 2007, Pages 107-110

  Lindh, Ulf ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; IRON; SELENIUM; TRACE ELEMENT; ZINC;

ASPECT; METAL;

DOSE RESPONSE; HUMAN; METABOLISM; REVIEW;

DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IODINE; IRON; SELENIUM; TRACE ELEMENTS; ZINC;

EID: 34247115684     PISSN: 00447447     EISSN: None     Source Type: Journal    
DOI: 10.1579/0044-7447(2007)36[107:MBAOBE]2.0.CO;2     Document Type: Review

References (34)

1. Cornah, J.E., Terry, M.J. and Smith, A.G. 2003. Green or red: what stops the traffic in the tetrapyrrole pathway? Trends Plant Sci. 8, 224-230.
2. Moulin, M. and Smith, A.G. 2005. Coenzymology: the biochemistry of vitamin biogenesis and cofactor-containing enzymes. Biochem. Soc. Transact. 33, 737-742.
3. Leboida, L. 2000. The honorary enzyme haemoglobin turns out to be a real enzyme. Cell Mol. Life Sci. 57, 1817-1819.
4. Ortiz de Montellano, P.R. and De Voss, J.J. 2002. Oxidizing species in the mechanism of cytochrome P-450. Nat. Prod. Rep. 19, 477-493.
5. Wilks, A. 2002. Heme oxygenase: evolution, structure, and mechanism. Anitox. Redox. Signal 4, 603-614.
6. Frazzon. J., Fick, J.R. and Dean, D.R. 2002. Biosynthesis of iron-sulphur clusters is a complex and highly conserved process. Biochem. Soc. Trans. 30, 680-685.
7. Baker, H.M., Anderson, B.F. and Baker, E. 2003. Dealing with iron: common structural principles in proteins that transport iron and heme. Proc. Natl. Acad. Sci. USA 100, 3579-3583.
8. Kruzel, M.L. and Zimecki, M. 2002. Lactoferrin and immunologic dissonance: clinical implications. Arch. Immunol. Ther. Exp. 50, 399-410.
9. Andrews, S.C., Robinson, A.K. and Rodrigues-Quinones, F. 2003. Bacterial iron homeostasis. FEMS Microbiol. Rev. 27, 215-237.
10. Trinder, D., Macey, D.J. and Olynyk, J.K. 2000. The new iron age. Int. J. Mol. Med. 6, 607-612.
11. Gerlach, M., Double, K.L., Youdim, M.B. and Riederer, P. 2006. Potential source of increased iron in the substantia nigra of parkinsonian patients. J. Neural Transm. Suppl. 70, 133-142.
12. Fasano, M., Bergamasco, B. and Lopiano, L. 2006. Modifications of the iron-neuromelanin system in Parkinson's disease. J. Neurochem. 96, 909-916.
13. LeVine, S.M. and Chakrabarty, A. 2004. The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann. NY Acad. Sci. 1012, 252-266.
14. Marcil, V., Delvin, E., Sane, AT., Tremblay, A. and Levy, E. 2006. Oxidative stress influences cholesterol efflux in THP-1 macrophages: role of ATP-binding cassette A1 and nuclear factors. Cardivasc. Res. 72, 473-482.
15. Spiteller, G. 2005. The relation of lipid peroxidation processes with atherogenesis: a new theory on atherogenesis. Mol. Nutr. Food Res. 49, 999-1013.
16. Nyström-Rosander, C, Lindh, U., Ilback, N.G., Hjelm, E., Thelin, S., Lindqvist, O. and Friman, G. 2003. Interactions between Chlamydia pneumoniae and trace elements: a possible link to aortic valve sclerosis. Biol. Trace Elem. Res. 91, 97-110.
17. Kartikasari, A.E., Georgiou, N.A., de Geest, M., van Kats-Renaud, J.H., Bouwman, J.J., van Asbeck, B.S., Marx, J.J. and Visseren, F.L. 2006. Iron enhances endothelial cell activation in response to Cytomegalovirus or Chlamydia pneumoniae infection. Eur. J. Clin. Invest. 36, 743-752.
18. Sterling, D., Reithmeier, R.A.F. and Casey, J.R. 2001. Carbonic anhydrase: in the driver's seat for bicarbonate transport. J. Pancreas (online) 2, 165-170.
19. Sträter, N., Sun, L., Kantrowitz, E.R. and Lipscomb, W.N. 1999. A bicarbonate ion as a general base in the mechanisms of peptide hydrolysis by dizinc leucine aminopeptidase. Proc. Natl. Acad. Sci. USA 96, 11151-11155.
20. Duester, G. 1998. Alcohol dehydrogenase as a critical mediator of retinoic acid synthesis from vitamin A in the mouse embryo. J. Nutr. 128, 459-462.
21. Barceloux, D.G., Bond, G.R., Krenzelok, E.P., Cooper, H. and Vale, J.A. 2002. American academy clinical toxicology practice guidelines on the treatment of methanol poisoning. J. Toxicol. Clin. Toxicol. 40, 415-446.
22. Cousins, R.J. 1998. A role of zinc in the regulation of gene expression. Proc. Nutr. Soc. 57, 307-311.
23. Falchuk, K.H. 1998. The molecular basis for the role of zinc in developmental biology, Mol. Cell. Biochem. 188, 41-48.
24. Dreosti, I.E. 2001. Zinc and the gene. Mutat. Res. 475, 161-167.
25. Sun, X. and Kang, Y.J. 2002. Prior increase in metallothionein levels is required to prevent doxorubicin cardiotoxicity. Exp. Biol. Med. 227, 652-657.
26. Coyle, P., Phicox, J.C., Carey, L.C. and Rofe, A.M. 2002. Metallothionein: the multipurpose protein. Cell. Mol. Life Sci. 59, 627-647.
27. Chausmer, A.B. 1998. Zinc, insulin and diabetes. J. Am. Coll. Nutr. 17, 109-115.
28. Dardenne, M. 2002. Zinc and immune function. Eur. J. Clin. Nutr. 56, 20-23.
29. Coindet, J.F. 1821. Novel research on the effects of iodine and the precautions during treatment of goiter by the new medicine. Ann. Chim. Phys. (Paris) 16, 252-266 (In French).
30. Maumené, E. 1854. Experiences of determining the action of fluorine on domestic animals. C. R. Acad. Sci. (Paris) 39, 538-539 (In French).
31. Moxon, A.L. 1937. Alkali disease, or selenium poisoning. South Dakota Agricultural Experimental Stations, Brookings. Bulletin 331.
32. Nelson, A.A., Fitzhugh, O.G. and Calvery, H.O. 1943. Liver tumors following cirrhosis caused by selenium in rats. Cancer Res. 3, 230-236.
33. Schwartz, K. and Foltz, CM. 1957. Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. J. Am. Chem. Soc. 79, 3292-3293.
34. Clark, L.C., Combs, G.F. Jr., Trumbull, B.W., Slate, E.H., Chalker, D.K., Chow, J., Davis, L.S., Glover, R.A. et al. 1996. Effects of selenium supplementation for cancer-prevention in patients with carcinoma of the skin. A randomized controlled trial Natl. Prev. Cancer Study Group 276, 1957-1963.